|
CCNDBP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.32319999799091E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.49769999630212E-08 |
| Normal-vs-Stage2 |
1.477080E-03 |
| Normal-vs-Stage3 |
1.158590E-04 |
| Normal-vs-Stage4 |
2.936700E-03 |
| Stage1-vs-Stage2 |
3.332600E-01 |
| Stage1-vs-Stage3 |
5.315000E-01 |
| Stage1-vs-Stage4 |
8.471800E-01 |
| Stage2-vs-Stage3 |
7.187400E-01 |
| Stage2-vs-Stage4 |
6.677800E-01 |
| Stage3-vs-Stage4 |
8.522000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.16550000153859E-08 |
| Normal-vs-AfricanAmerican |
4.09399999999893E-05 |
| Normal-vs-Asian |
1.915840E-01 |
| Caucasian-vs-AfricanAmerican |
2.056200E-01 |
| Caucasian-vs-Asian |
2.340200E-01 |
| AfricanAmerican-vs-Asian |
4.670400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.13830000980641E-09 |
| Normal-vs-Female |
1.018740E-03 |
| Male-vs-Female |
3.384000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.027900E-04 |
| Normal-vs-Extreme_Weight |
5.86489999898632E-08 |
| Normal-vs-Obese |
5.4157999995752E-07 |
| Normal-vs-Extreme_Obese |
4.31250000000327E-05 |
| Normal_Weight-vs-Extreme_Weight |
3.023800E-01 |
| Normal_Weight-vs-Obese |
7.454800E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.229800E-01 |
| Extreme_Weight-vs-Obese |
3.994800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.509800E-01 |
| Obese-vs-Extreme_Obese |
2.082200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.344500E-03 |
| Normal-vs-Age(41-60Yrs) |
3.45699999959592E-07 |
| Normal-vs-Age(61-80Yrs) |
1.56659999972497E-07 |
| Normal-vs-Age(81-100Yrs) |
1.424430E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.150800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.659400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.216400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.290000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.280600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.447200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.36510042053817E-10 |
| Normal-VS-Type2 PRCC |
3.9580000000039E-05 |
| Normal-VS-KIRP CIMP |
9.646400E-02 |
| Normal-VS-Unclassified PRCC |
1.80845999999679E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.219390E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.059900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.481200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.999200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.345800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.563450E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.46319999741962E-08 |
| Normal-vs-N1 |
1.985640E-04 |
| Normal-vs-N2 |
1.824290E-02 |
| N0-vs-N1 |
4.225200E-01 |
| N0-vs-N2 |
9.297400E-01 |
| N1-vs-N2 |
6.776400E-01 |
|
|
